Literature DB >> 6871085

Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis.

A R Penketh, M E Hodson, J C Batten.   

Abstract

Sixteen adults with cystic fibrosis and chronic bronchopulmonary infection with Pseudomonas aeruginosa, admitted to hospital for chemotherapy, were randomized to treatment with either carbenicillin or ticarcillin. In addition all patients received gentamicin. Both antibiotic treatments produced clinical improvement and significant improvement in respiratory function, but there was no difference between them. Pseudomonas aeruginosa was not eradicated from sputum with either treatment regimen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871085     DOI: 10.1016/0007-0971(83)90025-6

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  6 in total

Review 1.  Cystic fibrosis, pathophysiological and clinical aspects.

Authors:  H J Neijens; M Sinaasappel; R de Groot; J C de Jongste; S E Overbeek
Journal:  Eur J Pediatr       Date:  1990-08       Impact factor: 3.183

Review 2.  Duration of intravenous antibiotic therapy in people with cystic fibrosis.

Authors:  Amanda Plummer; Martin Wildman; Tim Gleeson
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

3.  Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.

Authors:  A Penketh; M E Hodson; H Gaya; J C Batten
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

4.  Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis.

Authors:  M J Smith; L O White; H Bowyer; J Willis; M E Hodson; J C Batten
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

5.  Is the improvement of CF patients, hospitalized for pulmonary exacerbation, correlated to a decrease in bacterial load?

Authors:  Pieter Deschaght; Petra Schelstraete; Leen Van Simaey; Marleen Vanderkercken; Ann Raman; Linda Mahieu; Sabine Van Daele; Frans De Baets; Mario Vaneechoutte
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

Review 6.  Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.

Authors:  Matthew N Hurley; Andrew P Prayle; Patrick Flume
Journal:  Cochrane Database Syst Rev       Date:  2015-07-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.